Safety and efficacy of tolebrutinib, an oral brain-penetrant BTK inhibitor, in relapsing multiple sclerosis: a phase 2b, randomised, double-blind, placebo-controlled trial
Resource Type
Article
Authors
Grand'Maison, Francois ; Jacques, Francois ; Traboulsee, Anthony ; Tyblova, Michaela ; Meluzinova, Eva ; Ampapa, Radek ; Valis, Martin ; Hradilke, Pavel ; Mareš, Miroslav ; Stourac, Pavel ; Gross-Paju, Katrin ; Laplaud, David ; Mathey, Guillaume ; Uitdehaag, Bernard ; Evdoshenkoo, Evgeny ; Popova, Ekaterina ; Zakharova, Maria ; Totolyan, Natalia ; Litvinenko, Igor ; Khabirov, Farit ; Sivertseva, Stella ; Hancinova, Viera ; Kantorova, Ema ; Gines, Maria Luisa Martinez ; Montalban, Xavier ; Maduano, Sara Eichau ; Meca-Lallana, Jose ; Ramió-Torrentà, Lluís ; Nehrych, Tetyanna ; Pashkovskyy, Valeriy ; Moskovko, Sergii ; Kalbus, Oleksandr ; Khavunka, Marta ; Pryshchepa, Volodymyr ; Goloborodko, Alla ; Wynn, Daniel ; Honeycutt, William ; Wray, Sibyl ; Steingo, Brian ; LaGanke, Christopher ; Huang, Deren ; Hemphill, John Michael ; Goldstick, Lawrence ; Robertson, Derrick ; Reich, Daniel S ; Arnold, Douglas L ; Vermersch, Patrick ; Bar-Or, Amit ; Fox, Robert J ; Matta, Andre ; Turner, Timothy ; Wallström, Erik ; Zhang, Xinyan ; Khabirov, Farit A
Source
In The Lancet Neurology September 2021 20(9):729-738
Subject
Primary Research Articles
Language
ISSN
1474-4422